GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (NYSE:ABBV) » Definitions » Shiller PE Ratio

AbbVie (AbbVie) Shiller PE Ratio : 35.16 (As of May. 22, 2024)


View and export this data going back to 2012. Start your Free Trial

What is AbbVie Shiller PE Ratio?

As of today (2024-05-22), AbbVie's current share price is $161.37. AbbVie's E10 for the quarter that ended in Mar. 2024 was $4.59. AbbVie's Shiller PE Ratio for today is 35.16.

The historical rank and industry rank for AbbVie's Shiller PE Ratio or its related term are showing as below:

ABBV' s Shiller PE Ratio Range Over the Past 10 Years
Min: 24.95   Med: 33.03   Max: 41.26
Current: 35.16

During the past years, AbbVie's highest Shiller PE Ratio was 41.26. The lowest was 24.95. And the median was 33.03.

ABBV's Shiller PE Ratio is ranked worse than
69.23% of 533 companies
in the Drug Manufacturers industry
Industry Median: 24.85 vs ABBV: 35.16

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

AbbVie's adjusted earnings per share data for the three months ended in Mar. 2024 was $0.770. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $4.59 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


AbbVie Shiller PE Ratio Historical Data

The historical data trend for AbbVie's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AbbVie Shiller PE Ratio Chart

AbbVie Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 32.44 34.42 36.48 34.31

AbbVie Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.89 29.83 32.56 34.31 39.63

Competitive Comparison of AbbVie's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, AbbVie's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AbbVie's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AbbVie's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where AbbVie's Shiller PE Ratio falls into.



AbbVie Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

AbbVie's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=161.37/4.59
=35.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AbbVie's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, AbbVie's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.77/131.7762*131.7762
=0.770

Current CPI (Mar. 2024) = 131.7762.

AbbVie Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.680 100.560 0.891
201409 0.310 100.428 0.407
201412 -0.510 99.070 -0.678
201503 0.630 99.621 0.833
201506 0.830 100.684 1.086
201509 0.740 100.392 0.971
201512 0.920 99.792 1.215
201603 0.830 100.470 1.089
201606 0.980 101.688 1.270
201609 0.970 101.861 1.255
201612 0.850 101.863 1.100
201703 1.060 102.862 1.358
201706 1.190 103.349 1.517
201709 1.010 104.136 1.278
201712 0.030 104.011 0.038
201803 1.740 105.290 2.178
201806 1.260 106.317 1.562
201809 1.810 106.507 2.239
201812 -1.235 105.998 -1.535
201903 1.650 107.251 2.027
201906 0.490 108.070 0.597
201909 1.260 108.329 1.533
201912 1.880 108.420 2.285
202003 2.020 108.902 2.444
202006 -0.460 108.767 -0.557
202009 1.290 109.815 1.548
202012 0.010 109.897 0.012
202103 1.990 111.754 2.347
202106 0.420 114.631 0.483
202109 1.780 115.734 2.027
202112 2.260 117.630 2.532
202203 2.510 121.301 2.727
202206 0.510 125.017 0.538
202209 2.210 125.227 2.326
202212 1.380 125.222 1.452
202303 0.130 127.348 0.135
202306 1.140 128.729 1.167
202309 1.000 129.860 1.015
202312 0.460 129.419 0.468
202403 0.770 131.776 0.770

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


AbbVie  (NYSE:ABBV) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


AbbVie Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of AbbVie's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AbbVie (AbbVie) Business Description

Address
1 North Waukegan Road, North Chicago, IL, USA, 60064-6400
AbbVie is a pharmaceutical firm with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Executives
Nicholas Donoghoe officer: SVP, Enterprise Innovation 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Susan E Quaggin director 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Jennifer L. Davis director 1 PROCTER & GAMBLE PLAZA, CINCINNATI OH 45202
Richard A Gonzalez officer: Chairman of the Board and CEO 1 N. WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Elaine K. Sorg officer: Sr. V.P., U.S. Commercial Ops. 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Perry C Siatis officer: EVP, GC and Secretary 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Jeffrey Ryan Stewart officer: SVP, US Commercial Operations 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Kevin K Buckbee officer: SVP, Controller 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Scott T Reents officer: SVP, Chief Financial Officer 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Azita Saleki-gerhardt officer: SVP, Operations 1 N. WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Carrie C Strom officer: SVP & Pres Global Allerg Aesth 1 N. WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Roxanne S Austin director 200 N SEPULVEDA BLVD, PO BOX 956 MS ES/001/A102, EL SEGUNDO CA 90245
Timothy J. Richmond officer: EVP, Chief HR Officer 1 N. WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Michael Severino officer: EVP, R&D and CSO 1 N. WAUKEGAN ROAD, NORTH CHICAGO IL 60064
Henry O Gosebruch officer: Chief Strategy Officer 1 N. WAUKEGAN ROAD, NORTH CHICAGO IL 60064-6092

AbbVie (AbbVie) Headlines

From GuruFocus

Q3 2022 Abbvie Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2021 Abbvie Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q1 2022 Abbvie Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024